Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers

NCT02257021 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BILR 355 BS
DRUG: Tipranavir
DRUG: Low dose of ritonavir
DRUG: High dose of ritonavir

Sponsor

Boehringer Ingelheim